Former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, Thursday, July 27, 2017, in New York.
News
- Shkreli portrayed as con, prodigy at securities fraud trial
- The Latest: 'Pharma Bro' jury to begin deliberations Monday
Former biotech CEO Martin Shkreli, right, leaves federal court with a member of his legal team Thursday, July 27, 2017, in New York. Shkreli's defense ...
- Institute to develop transplant organs for injured vets
Officials say it will bring good jobs to Manchester and give the state's college graduates opportunities to work on cutting-edge biomedical research.
- Facebook and Verizon advance while AstraZeneca dives
... up $2.85 to $133.92. The biotechnology company raised its forecasts after a strong second quarter and said it will cut some research programs.
- The Latest: Lawyer says Shkreli never bilked investors
A defense attorney at the securities fraud trial of former biotech CEO Martin Shkreli says his client didn't rip off investors. Lawyer Ben Brafman told the ...